How to Commercialise an Advanced Therapy: Lessons Learned and Future Plans

Andrea leads the Cell and Gene Therapy and Direct-to-Patient service lines, with a focus on defining strategy, driving growth and solving operational and process challenges which arise from the complexity of these shipments. With a wealth of expertise and experience gained across academia, pharmaceutical services and clinical trials logistics, Andrea has served in a number of senior leadership roles in research and development, clinical trial supply chain as well as product and project management before joining our team in 2021.

In parallel, Andrea is an active member of the ISPE (International Society for Pharmaceutical Engineering), the female manager network of the VBU (Verband der Biotechnologieunternehmen), HBA (Healthcare Business Women Association) and author for the PDA (Parentarel Drug Association) and RAPS (Regulatory Affairs Professionals Society).

Melissa is an Experienced Director with a demonstrated history of working in the pharmaceutical industry. Currently at AmerisourceBergen, Melissa oversees the commercialization in various therapeutic areas such as Cell & Gene and Biosimilar developments

Hans-Peter Scherzer has 13 years of experience within the logistics industry, five of which have been spent specifically within a healthcare logistics setting.

His roles have included operational, customer facing, and team management. Adding further to his background, he has been responsible for highly-strategic global roll-outs, managed global vendor onboarding, and successfully executed transformation and remediation projects. These invaluable experiences have afforded him a wide array of opportunities to build a deep and expansive understanding of the industry’s unique and complex requirements.